Internal Medicine · Miami, FL
NPI
1265546063
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
15516 SW 88th St
Miami, FL, 33196
Phone (305) 387-3300
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$620K
7,389 prescriptions
Company payments, 2025
$591
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jorge L Rodriguez Mendez prescribed most often to Medicare patients was Amlodipine Besylate, with 330 prescriptions and refills. In total Jorge L Rodriguez Mendez wrote 7,389 Medicare prescriptions that cost $620K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amlodipine Besylate Generic | 330 | 912 | 102 | $1,219 |
| Atorvastatin Calcium Generic | 329 | 953 | 109 | $2,340 |
| Eliquis Apixaban | 289 | 330 | 46 | $189K |
| Famotidine Generic | 288 | 752 | 95 | $2,571 |
| Metoprolol Succinate Generic | 271 | 738 | 79 | $3,949 |
| Losartan Potassium Generic | 262 | 706 | 82 | $2,798 |
| Gabapentin Generic | 226 | 493 | 67 | $1,808 |
| Rosuvastatin Calcium Generic | 169 | 480 | 58 | $1,261 |
| Pantoprazole Sodium Generic | 168 | 462 | 57 | $1,223 |
| Levothyroxine Sodium Generic | 146 | 413 | 55 | $1,808 |
| Furosemide Generic | 143 | 269 | 39 | $348 |
| Fluticasone Propionate Generic | 136 | 159 | 34 | $966 |
| Tradjenta Linagliptin | 126 | 142 | 15 | $72K |
| Irbesartan Generic | 125 | 360 | 37 | $2,628 |
| Tamsulosin Hcl Generic | 116 | 321 | 32 | $1,087 |
Brand drugs: 1,209 claims; generic drugs: 6,093 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge L Rodriguez Mendez $591 ($591 in general payments such as food, travel and fees) from 2 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $466.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.